Announcements Trials

Browse Landscape

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 39 Ovarian Neoplasms 29 Multiple Myeloma 16 Neoplasms 9 Recurrence 8 Lymphoma 8 Fallopian Tube Neoplasms 8 Triple Negative Breast Neoplasms 7 Lymphoma, Large B-Cell, Diffuse 7 Hodgkin Disease 7 Carcinoma, Ovarian Epithelial 7 Lymphoma, Non-Hodgkin 6 Sarcoma 5 Neoplasm Metastasis 5 Burkitt Lymphoma 3 Uterine Cervical Neoplasms 2 Prostatic Neoplasms 2 Pancreatic Neoplasms 2 Mesothelioma, Malignant 2 Lymphoma, Mantle-Cell 2 Lymphoma, Follicular 2 Lung Neoplasms 2 Liver Neoplasms 2 Leukemia 2 Leiomyosarcoma 2 Kidney Neoplasms 2 Endometrial Neoplasms 2 Disease Progression 2 Vulvar Neoplasms 1 Vaginal Neoplasms 1

Interventions

liposomal doxorubicin 1 cemiplimab 1 Paclitaxel 1 Doxorubicin 1 Cyclophosphamide 1 Carboplatin 1 Albumin-Bound Paclitaxel 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Invasive Breast Cancer × liposomal doxorubicin × Clear all

NCT04243616 2025-09-05

CemiHALT

Medical College of Wisconsin

Phase 2 Active not recruiting

Invasive Breast Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡